1Van’’tHof AW,TenBergJ,Heestermans T,et al.Prehospital initiation of tirofiban in patients with ST - elevation myocardial in- farction undergoing primary angioplasty (On—TIME 2 ):a multicentre, double - blind,randomised controlled trial[].The Lancet.2008
2SABATINE M S,MORROW D A,MONTALESCOT G,et al.Angiographic and clinaical outcomes in patients receiving low-molecular-weigt heparin versus unfractionated heparin in ST-ele-vation myocardial infarction treated with fibrinolytics the CLAR-ITY-TIMI 28 Trial[].Circulation.2005
3Kastrati A,Neumann FJ,Mehilli J,et al.ISAR - REACT 3 Trial In- ??vestigator.Bivalirudin unfractionated hevarin during pereutaneous coronary intervention[].The New England Journal of Medicine.2008
4Ogawa H,Nakayanm M,Morimoto T,et al.Low -dose aspirin for primary prevention of athereselerotic events in patients with type 2 diabetes:a randomized controlled trial[].The Journal of The American Medical Association.2008
5Antman EM,Wiviott SD,Murphy SA,et al.Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous eomnary interventiom:a TRITON - TIMI 38(TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel -Thrombolys[].Journal of the American College of Cardiology.2008
5Liu C, Cui J.Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease[J].Basic Clin Pharmacol Toxicol, 2009, 104 ( 2 ) : 101-106.
